---
$id: https://graph.org.ai/products/commodity/51291504
$type: Product
source: UNSPSC
code: "51291504"
title: "Cimoxatone"
class: "51291500"
classTitle: "Antidepressant azoles"
family: "51290000"
familyTitle: "Antidepressants"
segment: "51000000"
segmentTitle: "Pharmaceutical Products incl. Contraceptives and Vaccines"


---

# Cimoxatone

**UNSPSC Code**: 51291504
**Class**: [Antidepressant azoles](Antidepressant azoles.mdx)
**Family**: [Antidepressants](../Antidepressants.mdx)
**Segment**: [Pharmaceutical Products incl. Contraceptives and Vaccines](../../Pharmaceutical Products incl. Contraceptives and Vaccines.mdx)

This classification denotes a monoamine oxidase inhibitor with the molecular formula C19H18N2O4, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier V6FT1QJ7VL, chemically known as benzonitrile, 3-((4-(5-(methoxymethyl)-2-oxo-3-oxazolidinyl)phenoxy)methyl)- but generally known as cimoxatone, which bears US NIH Compound Identifier 52542. European Medicines Agency schedules Cimoxatone in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB06281MIG. The term CIMOXATONE is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 35, No. 5 1981, List 21). CIMOXATONE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule cimoxatone under HS 29349990 and SITC 51579. As of Q4 2014, CIMOXATONE remains the US FDA Preferred Term for this commodity. Cimoxatone bears US NLM identifiers UMLS ID C0109794 and NCI Concept Code C90879. SMILES: O1C(CN(c2ccc(OCc3cc(ccc3)C#N)cc2)C1=O)COC.

